4//SEC Filing
Li Yanbing 4
Accession 0001227025-21-000254
CIK 0001227025other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 4:45 PM ET
Size
18.7 KB
Accession
0001227025-21-000254
Insider Transaction Report
Form 4
Li Yanbing
Director
Transactions
- Sale
Common Stock
2021-12-09$15.33/sh−7,397$113,381→ 8,586 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2021-12-09−18,665→ 0 totalExercise: $4.37Exp: 2029-07-02→ Common Stock (18,665 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2021-12-09−3,820→ 3,821 totalExercise: $10.17Exp: 2031-05-31→ Common Stock (3,820 underlying) - Sale
Common Stock
2021-12-09$15.32/sh−3,820$58,541→ 15,983 total - Sale
Common Stock
2021-12-09$15.32/sh−18,665$286,037→ 15,983 total - Sale
Common Stock
2021-12-09$15.32/sh−8,960$137,310→ 15,983 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2021-12-09−8,960→ 0 totalExercise: $8.56Exp: 2030-06-01→ Common Stock (8,960 underlying) - Exercise/Conversion
Common Stock
2021-12-09$8.56/sh+8,960$76,698→ 24,943 total - Exercise/Conversion
Common Stock
2021-12-09$4.37/sh+18,665$81,566→ 34,648 total - Exercise/Conversion
Common Stock
2021-12-09$10.17/sh+3,820$38,849→ 19,803 total
Footnotes (1)
- [F1]This option shall vest ratably at a rate of 1/12th of the total number of shares granted on each monthly anniversary of the grant date, so long as the Reporting Person remains a member of the Board of Directors of the Company.
Documents
Issuer
NEOPHOTONICS CORP
CIK 0001227025
Entity typeother
Related Parties
1- filerCIK 0001783061
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 4:45 PM ET
- Size
- 18.7 KB